Insider · CIK 0001506218

Hardiman Roy C.

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001506218

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	ALMSALUMIS INC.S Sale	Chief Business & Strategy Ofcr	SSale	−2,692 sh	$26.37	−$71K	207,746
2026-01-26	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+191K sh	—	—	190,875
2025-07-29	ALMSALUMIS INC.A Award	Chief Business & Strategy Ofcr	AAward	+28K sh	—	—	206,401
2025-07-29	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+112K sh	—	—	111,950
2025-02-18	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+140K sh	—	—	140,000
2024-07-01	ALMSALUMIS INC.D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−6,417 sh	—	—	0
2024-07-01	ALMSALUMIS INC.A Award	Chief Business & Strategy Ofcr	AAward	+6,417 sh	—	—	6,417
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−42.8K sh	—	—	0
2024-07-01	ALMSALUMIS INC.D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−175K sh	—	—	0
2024-07-01	ALMSALUMIS INC.A Award	Chief Business & Strategy Ofcr	AAward	+175K sh	—	—	175,401
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+42.8K sh	—	—	42,780
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−152K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+152K sh	—	—	151,871
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−15K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+15K sh	—	—	14,973
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−30.6K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+30.6K sh	—	—	30,642
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−206K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+206K sh	—	—	206,074
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Business & Strategy Ofcr	DDisposition to Issuer	−53.5K sh	—	—	0
2024-07-01	ALMSALUMIS INC. · Stock Option (Right to Buy)A Award	Chief Business & Strategy Ofcr	AAward	+53.5K sh	—	—	53,475
2020-09-28	Principia Biopharma Inc.U Disposition from Tender	Chief Business Officer	UDisposition from Tender	−118K sh	$100.00	−$11.8M	0
2020-09-28	Principia Biopharma Inc.U Disposition from Tender	Chief Business Officer	UDisposition from Tender	−1,916 sh	$100.00	−$192K	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−11.5K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−44K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−60K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−55K sh	—	—	0
2020-09-18	Principia Biopharma Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,758 sh	$4.72	+$13K	120,519
2020-09-18	Principia Biopharma Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,242 sh	$7.27	+$16.3K	122,761
2020-09-18	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−5,000 sh	$99.98	−$500K	117,761
2020-09-18	Principia Biopharma Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,758 sh	—	—	0
2020-09-18	Principia Biopharma Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,242 sh	—	—	11,519
2020-06-12	Principia Biopharma Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,000 sh	$4.72	+$23.6K	122,761
2020-06-12	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−1,595 sh	$59.90	−$95.5K	121,166
2020-06-12	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−2,542 sh	$61.62	−$157K	118,624
2020-06-12	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−863 sh	$62.13	−$53.6K	117,761
2020-06-12	Principia Biopharma Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,000 sh	—	—	2,758
2020-03-13	Principia Biopharma Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+5,000 sh	$4.72	+$23.6K	121,903
2020-03-13	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−3,719 sh	$48.21	−$179K	118,184
2020-03-13	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−1,181 sh	$49.46	−$58.4K	117,003
2020-03-13	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−100 sh	$51.04	−$5,104	116,903
2020-03-13	Principia Biopharma Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−5,000 sh	—	—	7,758
2020-03-05	Principia Biopharma Inc.Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+55K sh	—	—	55,000
2019-12-30	Principia Biopharma Inc.G Gift	Chief Business Officer	GGift	−3,240 sh	—	—	116,903
2019-12-30	Principia Biopharma Inc.G Gift	Chief Business Officer	GGift	+540 sh	—	—	1,916
2019-12-13	Principia Biopharma Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+871 sh	$4.72	+$4,114.256	121,014
2019-12-13	Principia Biopharma Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,129 sh	$5.00	+$20.6K	125,143
2019-12-13	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−3,381 sh	$49.20	−$166K	121,762
2019-12-13	Principia Biopharma Inc.S Sale	Chief Business Officer	SSale	−1,619 sh	$49.83	−$80.7K	120,143
2019-12-13	Principia Biopharma Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−871 sh	—	—	12,758

Recent filings

Accepted (ET)
Aug 54
Hardiman Roy C.0001506218-26-000005
SEC(opens sec.gov)
Jan 284
Hardiman Roy C.0001506218-26-000003
SEC(opens sec.gov)
Jul 314
Hardiman Roy C.0001415889-25-020805
SEC(opens sec.gov)
Feb 204
Hardiman Roy C.0001415889-25-004958
SEC(opens sec.gov)
Jul 14
Hardiman Roy C.0001415889-24-018597
SEC(opens sec.gov)

Companies

Address

C/O ALUMIS INC. 280 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080